Drawing for TRIPATH ONCOLOGY

USPTO serial 76423903

TRIPATH ONCOLOGY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MCMORROW, RONALD G
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TRIPATH ONCOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

F. Andrew Anderson, Esq.

F ANDREW ANDERSON ESQ PALMER & DODGE LLP111 HUNTINGTON AVE AT PRUDENTIAL CENTBOSTON, MA 02199-7613UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic assay kits containing nucleic acid for research use in providing genomic and proteomic profiles useful in the selection of therapeutics for clinical medical use, diagnostic assay kits containing antibody reagents for research use in providing genomic and proteomic profiles useful in the selection of therapeutics for clinical medical useACTIVE—
005Diagnostic assay kits containing nucleic acid for diagnosing cancer, diagnostic assay kits containing antibody reagents for diagnosing cancer, diagnostic assays for diagnostic and therapeutic clinical medical use, and prescription pharmaceuticals for use in the diagnosis or treatment of human diseases, namely cancerACTIVE—
009Computer programs for use in cancer research namely, the analysis, data management, and data visualization of nucleic acid sequences and amino acid sequences, and for use in the identification and characterization of genes and proteins and computer programs for use in the management, storage, retrieval and analysis of data used in the discovery and development of diagnostic, prognostic, and therapeutic medical products for the treatment of cancerACTIVE—
042Research services, namely, research, development, validation, testing, data analysis and product development services in the field of cancer; research consulting services, namely, research, development, validation, testing, data analysis, and product development services for others in the field of cancerACTIVE—
044Medical and diagnostic services, namely, diagnosing, preventing, and predicting cancer, identifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative programs, establishing cancer treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and computer tracking of a patient's health progress; consultation services, namely, providing consultation to others via global, national, and local computer network in the field of cancer; and providing on-line computer databases via global, national, and local computer networks in the field of cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 13, 2006ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jun 13, 2006MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 13, 2006ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 12, 2005EX4GSOU EXTENSION 4 GRANTED—
Oct 7, 2005MAILPAPER RECEIVED—
Oct 6, 2005EXT4SOU EXTENSION 4 FILED—
Oct 6, 2005FAXXFAX RECEIVED—
Apr 4, 2005EX3GSOU EXTENSION 3 GRANTED—
Apr 4, 2005EXT3SOU EXTENSION 3 FILED—
Apr 4, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 19, 2004EX2GSOU EXTENSION 2 GRANTED—
Oct 4, 2004EXT2SOU EXTENSION 2 FILED—
Oct 4, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 9, 2004CFITCASE FILE IN TICRS—
Mar 31, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 21, 2004EX1GSOU EXTENSION 1 GRANTED—
Mar 21, 2004EXT1SOU EXTENSION 1 FILED—
Oct 7, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 15, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 25, 2003NPUBNOTICE OF PUBLICATION—
May 12, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 26, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 26, 2003TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 4, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 30, 2002DOCKASSIGNED TO EXAMINER—
Sep 23, 2002DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance